ACM Global Receives Top Accreditation Renewal from College of American Pathologists
ACM Global Central Laboratory, a central lab that specializes in delivering high quality testing services designed to optimize clinical trial outcomes, has renewed its College of American Pathologists (CAP) accreditation based on the results of a recent onsite inspection.
ACM Global Central Laboratory
, a central lab that specializes in delivering high quality testing services designed to optimize clinical trial outcomes, has renewed its College of American Pathologists (CAP) accreditation based on the results of a recent onsite inspection.
The College of American Pathology conducted its biennial assessment of ACM U.S. laboratory and pathology operations and found no deficiencies at the company’s laboratory facilities in Rochester, New York. Inspection processes consists of examining quality control procedures and lab records including staff qualifications, equipment, health and safety along with the overall management of the facility. This rigorous process is designed to ensure the highest standard of care for all laboratory patients of central labs worldwide, and is considered equal or more stringent than the U.S. federal government’s own inspection program.
“The CAP survey process is a rigorous, peer-to-peer assessment of our quality and technical proficiency across a comprehensive range of standards. Maintaining this accreditation clearly demonstrates our dedication to high level performance and best practices as a central lab,” said John D’Souza, MD, laboratory director.
To view a complete list of credentials, please visit the site at
www.acmgloballab.com/credentials.aspx
or visit us at
DIA 2013, booth #945
, June 24-28 for more information.
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus
May 7th 2025Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of treatment remained undetectable for nearly 2 years post-treatment.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
